HomeStock SectorsBioTechMassive 69.4% Surge for...

Massive 69.4% Surge for IGC Pharma in After-Hours Trading: Here’s Why – IGC Pharma (AMEX:IGC)

IGC Pharma Inc IGC witnessed a surge of 69.40%  in its stock value during after-hours trading on Wednesday.

What Happened: The stock of IGC Pharma, a company involved in the development of cannabinoid-based therapies for Alzheimer‘s disease, rose by 69.40% to $0.62. This surge followed the closing price of $0.37 on Wednesday.

See Also: Scott Bessent Never ‘Made Time’ For Japan’s Trade Negotiator, Says Economist, Yet The US Ally Got Hit With Trump Tariffs — How Should Tokyo Make Sense Of This?

IGC Pharma’s stock has been on a rollercoaster ride recently. The company’s stock value had dropped to $0.32 on Tuesday, but it has now rebounded in after-hours trading.

Why It Matters: IGC Pharma has been making significant strides in its field. In June, the company highlighted its fiscal year 2025 with clinical progress and Alzheimer’s drug development advances. This included the presentation of a scientific poster titled “Genetic Toxicity Evaluation Of Melatonin In The Bacterial Reverse Mutation Assay,” at the 2025 Genetic Toxicology Association Annual Meeting.

IGC Pharma also beat analyst estimates in its fourth-quarter earnings, reporting an earnings per share of $(0.01) and sales of $330 million, which beat the $305 million estimate. 

Earlier in July, IGC Pharma was also listed among the top health care stocks that were moving in the after-market session. This indicates that the company has been attracting investor attention.

Price Action: IGC Pharma shares closed the Wednesday market session 14.02% higher at $0.37 per share- Benzinga Pro Data

Benzinga Edge Stock Rankings shows IGC stock has Momentum in the 20th percentile. Additional performance details are available here.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo Courtesy: kikpokemon on Shutterstock.com

Read Next:

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Market News and Data brought to you by Benzinga APIs

Most Popular

More from Author

3 Things to Watch This Week: Trade-War Worries, Earnings, and Record Highs

After the long holiday weekend, we’re back to a full week...

The Energy Report: Peak Oil Demand

Just breaking… is discussing pausing their output production hikes from October,...

Why Is Pelthos Therapeutics Stock Trading Higher Thursday – Pelthos Therapeutics (AMEX:PTHS)

Pelthos Therapeutics Inc. PTHS on Thursday announced the launch of Zelsuvmi...

Read Now

Why Are Biotech Stocks Ultragenyx And Mereo Facing A Sell-Off? – Ultragenyx Pharmaceutical (NASDAQ:RARE), Mereo BioPharma Group (NASDAQ:MREO)

Ultragenyx Pharmaceutical Inc. RARE and Mereo BioPharma Group plc MREO stocks are plunging on Thursday.What Happened?The companies on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward...

3 Things to Watch This Week: Trade-War Worries, Earnings, and Record Highs

After the long holiday weekend, we’re back to a full week of trading. Here are a few things we’re watching for this week. First, trade-war headlines. The Trump Administration’s original deadline was July 9th, and while that date is still in focus for investors, it now appears that many...

The Energy Report: Peak Oil Demand

Just breaking… is discussing pausing their output production hikes from October, saying that we would not ever consume as much oil as we did in the past. As predicted the “Peak Demand” oil theory has been dis-proven again. The United Arab Emirates oil minister Suhail Al Mazroui said that...

Why Is Pelthos Therapeutics Stock Trading Higher Thursday – Pelthos Therapeutics (AMEX:PTHS)

Pelthos Therapeutics Inc. PTHS on Thursday announced the launch of Zelsuvmi (berdazimer) topical gel 10.3% for molluscum contagiosum (molluscum) in adults and pediatric patients one year of age and older.Zelsuvmi received a Novel Drug designation from the U.S. Food and Drug Administration in January 2024 and is...

FTSE 100, DAX Forecast: 2 Top Trades to Watch

rises to record highs, boosted by miners. hits record highs as investors await EU-US trade deal news.FTSE Rises to Record Highs, Boosted by MinersThe FTSE 100 has risen to a record high, boosted by the mining sector, as investors react to Trump’s latest tariff announcement. Anglo...

Short-Term Stability vs. Long-Term Tension: Gas Market Holds Steady

This analysis was conducted in cooperation with Anastasia Volkova- analyst (LSE). market signals remain mixed. Summer 2025 contracts held just above their median pre-expiry levels last week, staying within historical volatility ranges. In contrast, winter 2026-27 contracts remained firmly above the upper bounds of the 10-day pre-expiry...

Markets Today: Copper Saga Heats Up, More Tariffs and DAX Holds Firm Near All-Time

U.S. stock futures and the dollar slipped after President Donald Trump escalated trade tensions by announcing a 50% tariff on and sending new letters to raise tariffs on other countries.Asian Market Wrap dropped 0.3%, and the slipped 0.1% on Thursday. Treasuries and Asian stocks stayed...

A Big Piece of the BBB Puzzle: Lower Interest Rates

With published today, most Fed members eye this year, but are split on what are the next steps.  One must cynically wonder which of the members is eyeing Powell’s job.  President Trump has made no secret of how much he wants rate cuts, to the point of...

Nvidia Hits $4 Trillion Market Cap, Dow Jones Near ATH, Tariff and FOMC News

Nvidia (NASDAQ:) hit a $4 trillion market value on Wednesday, becoming the first public company to do so. Its stock rose 2.4% to $164, driven by strong demand for AI technology. Nvidia first passed the $2 trillion mark in February 2024, and first passed the $3 trillion mark...

Why OPEC+ Is Pumping Oil Fast and Playing Hardball

OPEC+ blindsided oil market participants, again, with a larger-than-expected oil production hike for August. Instead of the widely expected 411,000 barrels per day (bpd), the group of eight OPEC+ producers led by Saudi Arabia and Russia decided to add 548,000 bpd to their combined oil output next month. OPEC+...

What To Expect From Johnson & Johnson’s Q2 Earnings – Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson JNJ is set to release its second-quarter earnings on Wednesday, July 16. According to Benzinga Pro data, analysts estimate adjusted earnings of $2.68 per share and sales of $22.85 billion.While overall estimates for 2025 and beyond show only slight increases, investor attention is expected...

Why Is Kazia Stock Soaring Today – Kazia Therapeutics (NASDAQ:KZIA)

Kazia Therapeutics KZIA on Wednesday reported preliminary results from the first patient in its Phase 1b trial evaluating a combination regimen of Paxalisib, Merck & Co Inc’s MRK Keytruda (pembrolizumab), and standard chemotherapy after completing Cycle 1 (21 days) of dosing.The patient, a 61-year-old woman with metastatic...